These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7088828)

  • 1. Drug treatment of depression in general practice.
    Wheatley D; Little JC
    Practitioner; 1982 Feb; 226(1364):316-20. PubMed ID: 7088828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term treatment of patients in neurological practices with antidepressive agents].
    Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1984 Mar; 55(3):137-42. PubMed ID: 6425705
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost effectiveness of botulinum toxins for the treatment of depression: preliminary observations.
    Beer K
    J Drugs Dermatol; 2010 Jan; 9(1):27-30. PubMed ID: 20120422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative somatic treatments for depression.
    Zajecka JM; Fawcett J
    Psychiatr Med; 1991; 9(1):77-103. PubMed ID: 2017569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experimentation with lorazepam (Temesta) in ambulatory practice].
    Aflalo M; Berkowitch S; Thielemans G; Vermeylen J
    Acta Psychiatr Belg; 1972 Nov; 72(6):756-66. PubMed ID: 4679558
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid hormone and the TRH stimulation test in refractory depression.
    Targum SD; Greenberg RD; Harmon RL; Kessler K; Salerian AJ; Fram DH
    J Clin Psychiatry; 1984 Aug; 45(8):345-6. PubMed ID: 6746579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug combinations in the treatment of depression].
    des Lauriers A; Puech A; Allilaire JF
    Sem Hop; 1982 Nov; 58(42):2432-9. PubMed ID: 6130602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
    Mendels J; Johnston R; Mattes J; Riesenberg R
    Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of medication on the course of major depression: a 3-year-follow-up with polydiagnostic measures.
    Frommberger U; Philipp M; Maier W
    Pharmacopsychiatry; 1988 Nov; 21(6):376-7. PubMed ID: 3244772
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L; Nielsen B; Stage KB; Brøsen K; Damkier P
    Nord J Psychiatry; 2008; 62(3):242-9. PubMed ID: 18622885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateralized neuropsychological functioning in depressive patients before and after drug therapy.
    de Groot MH; Nolen WA; Huijsman AM; Bouvy PF
    Biol Psychiatry; 1996 Dec; 40(12):1282-7. PubMed ID: 8959293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
    Cassano GB; Conti L; Dell'Osso L; Massimetti G
    Adv Biochem Psychopharmacol; 1982; 32():125-39. PubMed ID: 7046361
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of anxious depression in psychiatric outpatients.
    Henry BW; Markette J; Emken R; Overall J
    Dis Nerv Syst; 1969 Oct; 30(10):675-9. PubMed ID: 5355299
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid treatment of depression with selegiline-phenylalanine combination.
    Sabelli HC
    J Clin Psychiatry; 1991 Mar; 52(3):137. PubMed ID: 1900832
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of bifemelane hydrochloride on depressive illness of the elderly.
    Yamagami S; Koide S; Mui K; Perk S; Hirayama E; Kioka T; Soejima K; Inoue K; Nishiwaki S
    Int J Clin Pharmacol Res; 1995; 15(1):1-7. PubMed ID: 7490169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.